Repositioning Candidate Details
| Candidate ID: | R1043 |
| Source ID: | DB06538 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | Robalzotan |
| Synonyms: | (R)-3-(Dicyclobutylamino)-8-fluoro-5-chromancarboxamide; Robalzotan |
| Molecular Formula: | C18H23FN2O2 |
| SMILES: | NC(=O)C1=C2C[C@H](COC2=C(F)C=C1)N(C1CCC1)C1CCC1 |
| Structure: |
|
| DrugBank Description: | -- |
| CAS Number: | 169758-66-1 |
| Molecular Weight: | 318.392 |
| DrugBank Indication: | Investigated for use/treatment in anxiety disorders and depression. |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | 5-hydroxytryptamine receptor 1A |
| Inclusion Criteria: | Indication associated |
